CD47 agonist peptide PKHB1 induces immunogenic cell death in T‐cell acute lymphoblastic leukemia cells

T‐cell acute lymphoblastic leukemia (T‐ALL) has a poor prognosis derived from its genetic heterogeneity, which translates to a high chemoresistance. Recently, our workgroup designed thrombospondin‐1‐derived CD47 agonist peptides and demonstrated their ability to induce cell death in chronic lymphocy...

Descripción completa

Detalles Bibliográficos
Autores principales: Uscanga‐Palomeque, Ashanti Concepción, Calvillo‐Rodríguez, Kenny Misael, Gómez‐Morales, Luis, Lardé, Eva, Denèfle, Thomas, Caballero‐Hernández, Diana, Merle‐Béral, Hélène, Susin, Santos A., Karoyan, Philippe, Martínez‐Torres, Ana Carolina, Rodríguez‐Padilla, Cristina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6317946/
https://www.ncbi.nlm.nih.gov/pubmed/30460757
http://dx.doi.org/10.1111/cas.13885

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6317946/
https://www.ncbi.nlm.nih.gov/pubmed/30460757
http://dx.doi.org/10.1111/cas.13885

Ejemplares similares